Eledon Pharmaceuticals, Inc. - Common Stock — Bilancio Trimestrale (NASDAQ:ELDN) | MetaTrader

Apri il grafico completo Full chart

Notizie

Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year?

Eledon presenterà i dati del trial su trapianto renale a una conferenza

EXCLUSIVE: NewcelX Eyes Accelerated 2026 Execution For Diabetes Drug - NewcelX (NASDAQ:NCEL)

NewcelX aggiorna la presentazione sulla collaborazione per la terapia del diabete

Leerink Partners conferma rating Outperform su Eledon a $5

Leerink Partners reiterates Outperform on Eledon stock at $5

Eledon reports insulin independence in islet transplant trial

NewcelX collabora con Eledon per terapia diabete tipo 1

NewcelX partners with Eledon on type 1 diabetes therapy

Eledon Pharmaceuticals at Guggenheim Summit: Tegoprubart’s Promising Path

Eledon riporta dati positivi a 24 mesi sul trapianto di rene per tegoprubart

Eledon reports positive 24-month kidney transplant data for tegoprubart